CELLKINE CLINICAL TRIAL: FIRST REPORT FROM A PHASE I TRIAL OF ALLOGENEIC BONE MARROW-DERIVED MESENCHYMAL STEM CELLS IN SUBJECTS WITH PAINFUL LUMBAR FACET JOINT ARTHROPATHY

• Published in: Cytotherapy (Oxford, England) Vol. 26; no. 6; pp. e8 - e9
• Main Authors: Yan, D., Zubair, A., Osborne, M., Rosado, R. Pagan, Stone, J.A., Lehman, V., Durand, N., Kubrova, E., Wang, Z., Witter, D.M., Baer, M.M., Ponce, G.C., Quiñones-Hinojosa, A., Qu, W.
• Format: Journal Article
• Language: English
• Published: Elsevier Inc 01.06.2024
• Subjects: Advanced Basic Science; Bone-Marrow Mesenchymal Stem Cell; Case Report; Other; Painful Lumbar Facet Joint Arthropathy; Bone-Marrow Mesenchymal Stem Cell; Painful Lumbar Facet Joint Arthropathy; Case Report

Lumbar facet joint arthropathy (LFJA) is a leading cause of low back pain (LBP); however, current treatment options lack the ability to provide long-term benefits. Bone marrow-derived mesenchymal stem cells (BM-MSCs) are of particular interest owing to their potential immunomodulatory and trophic im...